About
The Updated NHS Commercial Framework for New Medicines
Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
The Covington European Life Sciences Symposium 2025
New ABPI Code and PMCPA Constitution and Procedure Published
Consultation on Changes to the ABPI Code and UK Advertising Complaints Process
EU Talking Life Sciences Audiocast: Major Changes to the UK’s Price Control Schemes for Branded Medicines – VPAG and the New Statutory Scheme – What You Need to Know
VPAG – New 5-Year Pricing Agreement Agreed between UK Government and the UK Pharmaceutical Industry Body (ABPI)